Kidney Disease and Fertility

Chronic kidney disease (CKD) affects roughly 37 million Americans, and many of them are of reproductive age. Yet fertility is rarely discussed in nephrology appointments until a patient is already trying and struggling. The reality is that CKD affects reproductive function in both men and women through multiple pathways, and the impact escalates with disease severity.

How CKD Stage Affects Reproductive Function

CKD is classified in five stages based on glomerular filtration rate (GFR), a measure of how well the kidneys filter waste. Reproductive effects track alongside disease progression, though not perfectly.

Female Reproductive Effects

The mechanisms are layered. Uremic toxins disrupt the hypothalamic-pituitary-ovarian axis, leading to elevated LH, reduced estrogen, and impaired follicular development. As kidney function declines, hyperprolactinemia becomes more common, further suppressing ovulation.

Anemia, which accompanies moderate to advanced CKD, contributes to fatigue and reduced libido. Medications used to manage CKD, including certain antihypertensives and immunosuppressants, can also interfere with reproductive function.

For women with early-stage CKD (stages 1 to 2), fertility is often preserved, and pregnancy is generally safe with appropriate monitoring. The critical conversations are about blood pressure control, proteinuria management, and medication safety during pregnancy.

Male Reproductive Effects

Men with CKD face a cluster of hormonal disruptions that compound as kidney function declines. The uremic environment suppresses gonadotropin-releasing hormone (GnRH) pulsatility, which in turn reduces LH and FSH signaling to the testes. The result is lower testosterone production, reduced spermatogenesis, and in many cases, erectile dysfunction.

Zinc deficiency, common in CKD and especially in dialysis patients, further impairs testosterone synthesis and sperm maturation. Prolactin elevation from impaired renal clearance adds another layer of reproductive suppression.

Dialysis and Fertility

Conception on dialysis is rare but not impossible. Among women of reproductive age on hemodialysis, pregnancy rates are estimated at 1 to 7% per year. Intensive daily or nocturnal dialysis regimens (more than 20 hours per week) have been associated with better fertility and pregnancy outcomes than conventional thrice-weekly schedules.

For men on dialysis, sperm parameters are typically poor. Hormonal disruption is near-universal, and the dialysis procedure itself adds oxidative stress. Sperm banking before starting dialysis, if the timeline allows, is worth discussing.

Transplant and the Fertility Window

A successful kidney transplant often substantially restores reproductive function. Menstrual cycles typically return within months of transplant, and hormonal profiles improve significantly. The same holds for men: testosterone levels and sperm production generally recover, though not always to pre-disease levels.

The standard recommendation is to wait 1 to 2 years post-transplant before attempting conception. This allows time for graft stabilization, achievement of maintenance immunosuppression doses, and resolution of any post-transplant complications.

Medication adjustments are critical. Mycophenolate mofetil (CellCept) is teratogenic and must be switched to azathioprine well before conception. Sirolimus and everolimus are typically avoided. Tacrolimus and cyclosporine are considered acceptable during pregnancy, though they require level monitoring.

Pregnancy with CKD: What the Data Shows

Pregnancy in women with CKD is higher-risk, and the risk scales with disease severity. Key concerns include:

• Preeclampsia (rates 3 to 5 times higher than the general population in advanced CKD)
• Accelerated decline in kidney function during and after pregnancy
• Preterm delivery (particularly common in stages 3 to 5)
• Fetal growth restriction

Women with proteinuria above 1 g/day and hypertension before pregnancy face the highest complication rates. The decision to pursue pregnancy with advanced CKD should involve both a nephrologist and a maternal-fetal medicine specialist, ideally before conception.